dendritic cell vaccine (University of Maryland/Hasumi)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedendritic cell vaccine (University of Maryland/Hasumi)
Drug Alias Namehead and neck cancer dendritic cell vaccine (University of Maryland/Hasumi)
ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHasumi International Research FoundationUniversity Of Maryland
Active IndicationsN/A
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A